← Open Payments lookup

RACHEL TAYLOR: Open Payments

NPI 1700532744 · OPELOUSAS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,157 in 55 payments from 14 companies in 2025. Trend: 2023 $418 · 2024 $1,100 · 2025 $1,157

Food & beverage: $1,145Education: $12
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$379
Alkermes, Inc.11$208
Vanda Pharmaceuticals Inc.8$148
ABBVIE INC.5$90
Axsome Therapeutics, Inc.3$72
Teva Pharmaceuticals USA, Inc.2$49
Lilly USA, LLC2$40
E.R. Squibb & Sons, L.L.C.2$39
Neurocrine BioSciences, Inc.1$32
Janssen Pharmaceuticals, Inc1$28

Products named: CAPLYTA, FANAPT, ARISTADA, VRAYLAR, LYBALVI, Auvelity, UZEDY, MOUNJARO.

Industry payments across LA — which companies pay providers there.